Suppression of allograft rejection by CD8+CD122+PD-1+Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis
机构:[1]Section of Immunology, Guangdong Provincial Academy of Chinese Medical Sciences, and Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, P.R. China广东省中医院[2]Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P.R. China[3]Student Exchange Program, Mayo Clinic, Rochester, MN, USA[4]Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, Guangdong, P.R. China
Mounting evidence has shown that naturally occurring CD8+CD122+ T cells are regulatory T cells (Tregs) that suppress both autoimmunity and alloimmunity. We have previously shown that CD8+CD122+PD-1+ Tregs not only suppress allograft rejection, but also are more potent in suppression than conventional CD4+CD25+ Tregs. However, the mechanisms underlying their suppression of alloimmunity are not well understood. In an adoptive T-cell transfer model of mice lacking lymphocytes, we found that suppression of skin allograft rejection by CD8+CD122+PD-1+ Tregs was mostly dependent on their expression of Fas ligand as either lacking Fas ligand or blocking it with antibodies largely abolished their suppression of allograft rejection mediated by transferred T cells. Their suppression was also mostly reversed when effector T cells lacked Fas receptor. Indeed, these FasL+Tregs induced T cell apoptosis in vitro in a Fas/FasL-dependent manner. However, their suppression of T cell proliferation in vitro was dependent on IL-10, but not FasL expression. Furthermore, adoptive transfer of CD8+CD122+PD-1+ Tregs significantly extended allograft survival even in wild-type mice if Tregs lacked Fas receptor or if recipients received recombinant IL-15, as these two measures synergistically expanded adoptively-transferred Tregs in recipients. Thus, this study may have important implications for Treg therapies in clinical transplantation.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [NSFC 81471550]
第一作者机构:[1]Section of Immunology, Guangdong Provincial Academy of Chinese Medical Sciences, and Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, P.R. China
通讯作者:
推荐引用方式(GB/T 7714):
Huazhen Liu,Yeshu Wang,Qiaohuang Zeng,et al.Suppression of allograft rejection by CD8+CD122+PD-1+Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis[J].ONCOTARGET.2017,8(15):24187-24195.doi:10.18632/oncotarget.15551.
APA:
Huazhen Liu,Yeshu Wang,Qiaohuang Zeng,Yu-Qun Zeng,Chun-Ling Liang...&Zhenhua Dai.(2017).Suppression of allograft rejection by CD8+CD122+PD-1+Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.ONCOTARGET,8,(15)
MLA:
Huazhen Liu,et al."Suppression of allograft rejection by CD8+CD122+PD-1+Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis".ONCOTARGET 8..15(2017):24187-24195